Dr. Gabriele Schmoetzer has been appointed head of regulatory affairs, Germany, at PSI CRO. Dr. Schmoetzer will supervise all regulatory-related activities for Germany, Austria and Switzerland.
Dr. Schmoetzer brings 24 years of clinical research experience, having worked for small, mid-size and large CROs. She has held positions in international and global project management, regulatory affairs, where she has held managerial positions, and has been responsible for clinical trial submissions in Germany and a number of other EU countries. Dr. Schmoetzer has experience with RA-specific processes and brings both technical expertise and extensive knowledge of the clinical trial regulatory environment.